HUBS vs MDGL · P/E 96, rev $1.79B vs rev $675.6M
HubSpot Inc (HUBS) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the HUBS and MDGL stock pages for the full models.
Not investment advice.